Product NDC: | 54473-578 |
Proprietary Name: | Triple Antibiotic |
Non Proprietary Name: | Bacitracin zinc and Neomycin and Polymyxin B sulfate |
Active Ingredient(s): | 500; 3.5; 10000 [iU]/g; mg/g; [iU]/g & nbsp; Bacitracin zinc and Neomycin and Polymyxin B sulfate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54473-578 |
Labeler Name: | Melaleuca, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part333B |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 19950701 |
Package NDC: | 54473-578-01 |
Package Description: | 14 g in 1 TUBE (54473-578-01) |
NDC Code | 54473-578-01 |
Proprietary Name | Triple Antibiotic |
Package Description | 14 g in 1 TUBE (54473-578-01) |
Product NDC | 54473-578 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Bacitracin zinc and Neomycin and Polymyxin B sulfate |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 19950701 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Melaleuca, Inc. |
Substance Name | BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE |
Strength Number | 500; 3.5; 10000 |
Strength Unit | [iU]/g; mg/g; [iU]/g |
Pharmaceutical Classes |